nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—pancreatic cancer	0.402	1	CbGaD
Oxaprozin—Methadone—Tamoxifen—pancreatic cancer	0.131	0.298	CrCrCtD
Oxaprozin—Benzphetamine—Tamoxifen—pancreatic cancer	0.11	0.249	CrCrCtD
Oxaprozin—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.102	0.231	CrCrCtD
Oxaprozin—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0974	0.221	CrCrCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000183	0.00116	CcSEcCtD
Oxaprozin—Paraesthesia—Gemcitabine—pancreatic cancer	0.000183	0.00116	CcSEcCtD
Oxaprozin—Asthenia—Sunitinib—pancreatic cancer	0.000182	0.00115	CcSEcCtD
Oxaprozin—Decreased appetite—Irinotecan—pancreatic cancer	0.000182	0.00115	CcSEcCtD
Oxaprozin—Arrhythmia—Docetaxel—pancreatic cancer	0.000181	0.00115	CcSEcCtD
Oxaprozin—Dyspnoea—Gemcitabine—pancreatic cancer	0.000181	0.00115	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000181	0.00115	CcSEcCtD
Oxaprozin—Insomnia—Fluorouracil—pancreatic cancer	0.000181	0.00115	CcSEcCtD
Oxaprozin—Somnolence—Gemcitabine—pancreatic cancer	0.000181	0.00115	CcSEcCtD
Oxaprozin—Paraesthesia—Fluorouracil—pancreatic cancer	0.00018	0.00114	CcSEcCtD
Oxaprozin—Alopecia—Docetaxel—pancreatic cancer	0.00018	0.00114	CcSEcCtD
Oxaprozin—Pruritus—Sunitinib—pancreatic cancer	0.000179	0.00114	CcSEcCtD
Oxaprozin—Constipation—Irinotecan—pancreatic cancer	0.000179	0.00113	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000178	0.00113	CcSEcCtD
Oxaprozin—Dyspnoea—Fluorouracil—pancreatic cancer	0.000178	0.00113	CcSEcCtD
Oxaprozin—Somnolence—Fluorouracil—pancreatic cancer	0.000178	0.00113	CcSEcCtD
Oxaprozin—Decreased appetite—Gemcitabine—pancreatic cancer	0.000177	0.00112	CcSEcCtD
Oxaprozin—Dyspepsia—Fluorouracil—pancreatic cancer	0.000176	0.00112	CcSEcCtD
Oxaprozin—Nausea—Tamoxifen—pancreatic cancer	0.000176	0.00112	CcSEcCtD
Oxaprozin—Gastritis—Epirubicin—pancreatic cancer	0.000175	0.00111	CcSEcCtD
Oxaprozin—Constipation—Gemcitabine—pancreatic cancer	0.000174	0.0011	CcSEcCtD
Oxaprozin—Nausea—Erlotinib—pancreatic cancer	0.000174	0.0011	CcSEcCtD
Oxaprozin—Decreased appetite—Fluorouracil—pancreatic cancer	0.000174	0.0011	CcSEcCtD
Oxaprozin—Diarrhoea—Sunitinib—pancreatic cancer	0.000173	0.0011	CcSEcCtD
Oxaprozin—Dysgeusia—Docetaxel—pancreatic cancer	0.000173	0.0011	CcSEcCtD
Oxaprozin—Feeling abnormal—Irinotecan—pancreatic cancer	0.000172	0.00109	CcSEcCtD
Oxaprozin—Asthma—Epirubicin—pancreatic cancer	0.000171	0.00109	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000171	0.00108	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—pancreatic cancer	0.00017	0.00108	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—pancreatic cancer	0.000168	0.00107	CcSEcCtD
Oxaprozin—Dizziness—Sunitinib—pancreatic cancer	0.000168	0.00106	CcSEcCtD
Oxaprozin—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000168	0.00106	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000167	0.00106	CcSEcCtD
Oxaprozin—Abdominal pain—Irinotecan—pancreatic cancer	0.000165	0.00105	CcSEcCtD
Oxaprozin—Body temperature increased—Irinotecan—pancreatic cancer	0.000165	0.00105	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000165	0.00105	CcSEcCtD
Oxaprozin—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000165	0.00105	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—pancreatic cancer	0.000163	0.00104	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—pancreatic cancer	0.000163	0.00103	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—pancreatic cancer	0.000162	0.00103	CcSEcCtD
Oxaprozin—Vomiting—Sunitinib—pancreatic cancer	0.000161	0.00102	CcSEcCtD
Oxaprozin—Body temperature increased—Gemcitabine—pancreatic cancer	0.000161	0.00102	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—pancreatic cancer	0.00016	0.00102	CcSEcCtD
Oxaprozin—Rash—Sunitinib—pancreatic cancer	0.00016	0.00101	CcSEcCtD
Oxaprozin—Dermatitis—Sunitinib—pancreatic cancer	0.00016	0.00101	CcSEcCtD
Oxaprozin—Urticaria—Fluorouracil—pancreatic cancer	0.000159	0.00101	CcSEcCtD
Oxaprozin—Headache—Sunitinib—pancreatic cancer	0.000159	0.00101	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—pancreatic cancer	0.000159	0.00101	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—pancreatic cancer	0.000158	0.00101	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—pancreatic cancer	0.000158	0.001	CcSEcCtD
Oxaprozin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000158	0.001	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000157	0.000995	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—pancreatic cancer	0.000156	0.000992	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000156	0.000992	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000155	0.000987	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000155	0.000986	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000154	0.00098	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—pancreatic cancer	0.000154	0.000975	CcSEcCtD
Oxaprozin—Convulsion—Docetaxel—pancreatic cancer	0.000153	0.000973	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—pancreatic cancer	0.000153	0.000969	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—pancreatic cancer	0.000153	0.000969	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000151	0.000961	CcSEcCtD
Oxaprozin—Nausea—Sunitinib—pancreatic cancer	0.000151	0.000956	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—pancreatic cancer	0.00015	0.000955	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—pancreatic cancer	0.00015	0.000952	CcSEcCtD
Oxaprozin—Asthenia—Irinotecan—pancreatic cancer	0.00015	0.000951	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—pancreatic cancer	0.000149	0.000944	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—pancreatic cancer	0.000149	0.000944	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000148	0.000942	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—pancreatic cancer	0.000148	0.00094	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—pancreatic cancer	0.000147	0.000935	CcSEcCtD
Oxaprozin—Asthenia—Gemcitabine—pancreatic cancer	0.000146	0.000926	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—pancreatic cancer	0.000146	0.000924	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—pancreatic cancer	0.000146	0.000924	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000145	0.000918	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—pancreatic cancer	0.000144	0.000916	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000144	0.000916	CcSEcCtD
Oxaprozin—Pruritus—Gemcitabine—pancreatic cancer	0.000144	0.000913	CcSEcCtD
Oxaprozin—Infection—Docetaxel—pancreatic cancer	0.000143	0.00091	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—pancreatic cancer	0.000143	0.000909	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000143	0.000907	CcSEcCtD
Oxaprozin—Diarrhoea—Irinotecan—pancreatic cancer	0.000143	0.000907	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000142	0.000904	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—pancreatic cancer	0.000142	0.000902	CcSEcCtD
Oxaprozin—Shock—Docetaxel—pancreatic cancer	0.000142	0.000901	CcSEcCtD
Oxaprozin—Pruritus—Fluorouracil—pancreatic cancer	0.000141	0.000898	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000141	0.000897	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—pancreatic cancer	0.000141	0.000896	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—pancreatic cancer	0.000141	0.000894	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00014	0.000889	CcSEcCtD
Oxaprozin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000139	0.000883	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—pancreatic cancer	0.000139	0.000881	CcSEcCtD
Oxaprozin—Dizziness—Irinotecan—pancreatic cancer	0.000138	0.000876	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—pancreatic cancer	0.000138	0.000874	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—pancreatic cancer	0.000138	0.000874	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—pancreatic cancer	0.000138	0.000874	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—pancreatic cancer	0.000138	0.000873	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000137	0.000871	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—pancreatic cancer	0.000137	0.00087	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—pancreatic cancer	0.000137	0.00087	CcSEcCtD
Oxaprozin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000137	0.000868	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—pancreatic cancer	0.000135	0.000856	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—pancreatic cancer	0.000135	0.000855	CcSEcCtD
Oxaprozin—Vomiting—Irinotecan—pancreatic cancer	0.000133	0.000843	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—pancreatic cancer	0.000133	0.000841	CcSEcCtD
Oxaprozin—Dizziness—Fluorouracil—pancreatic cancer	0.000132	0.000839	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000132	0.000837	CcSEcCtD
Oxaprozin—Rash—Irinotecan—pancreatic cancer	0.000132	0.000836	CcSEcCtD
Oxaprozin—Dermatitis—Irinotecan—pancreatic cancer	0.000132	0.000835	CcSEcCtD
Oxaprozin—Headache—Irinotecan—pancreatic cancer	0.000131	0.00083	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—pancreatic cancer	0.000131	0.000829	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—pancreatic cancer	0.00013	0.000823	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—pancreatic cancer	0.00013	0.000822	CcSEcCtD
Oxaprozin—Vomiting—Gemcitabine—pancreatic cancer	0.000129	0.000821	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—pancreatic cancer	0.000129	0.000817	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—pancreatic cancer	0.000128	0.000814	CcSEcCtD
Oxaprozin—Rash—Gemcitabine—pancreatic cancer	0.000128	0.000814	CcSEcCtD
Oxaprozin—Dermatitis—Gemcitabine—pancreatic cancer	0.000128	0.000813	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—pancreatic cancer	0.000128	0.000811	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000127	0.000809	CcSEcCtD
Oxaprozin—Headache—Gemcitabine—pancreatic cancer	0.000127	0.000809	CcSEcCtD
Oxaprozin—Vomiting—Fluorouracil—pancreatic cancer	0.000127	0.000807	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—pancreatic cancer	0.000127	0.000806	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000127	0.000805	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—pancreatic cancer	0.000127	0.000805	CcSEcCtD
Oxaprozin—Rash—Fluorouracil—pancreatic cancer	0.000126	0.0008	CcSEcCtD
Oxaprozin—Dermatitis—Fluorouracil—pancreatic cancer	0.000126	0.0008	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—pancreatic cancer	0.000125	0.000796	CcSEcCtD
Oxaprozin—Headache—Fluorouracil—pancreatic cancer	0.000125	0.000795	CcSEcCtD
Oxaprozin—Nausea—Irinotecan—pancreatic cancer	0.000124	0.000787	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—pancreatic cancer	0.000123	0.000783	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—pancreatic cancer	0.000122	0.000777	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—pancreatic cancer	0.000121	0.000769	CcSEcCtD
Oxaprozin—Nausea—Gemcitabine—pancreatic cancer	0.000121	0.000767	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00012	0.000761	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000119	0.000755	CcSEcCtD
Oxaprozin—Nausea—Fluorouracil—pancreatic cancer	0.000119	0.000754	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—pancreatic cancer	0.000118	0.00075	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000118	0.000749	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—pancreatic cancer	0.000118	0.000746	CcSEcCtD
Oxaprozin—Tension—Epirubicin—pancreatic cancer	0.000117	0.000743	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—pancreatic cancer	0.000117	0.000741	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—pancreatic cancer	0.000116	0.000735	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—pancreatic cancer	0.000114	0.000724	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—pancreatic cancer	0.000114	0.000724	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000113	0.000719	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—pancreatic cancer	0.000112	0.000714	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—pancreatic cancer	0.000112	0.000711	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000111	0.000703	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—pancreatic cancer	0.00011	0.0007	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—pancreatic cancer	0.000109	0.00069	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—pancreatic cancer	0.000108	0.000687	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000108	0.000686	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—pancreatic cancer	0.000108	0.000683	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—pancreatic cancer	0.000107	0.00068	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—pancreatic cancer	0.000107	0.00068	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—pancreatic cancer	0.000107	0.000679	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—pancreatic cancer	0.000107	0.000678	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—pancreatic cancer	0.000105	0.000669	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000105	0.000665	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—pancreatic cancer	0.000104	0.00066	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—pancreatic cancer	0.000104	0.000657	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—pancreatic cancer	0.000103	0.000656	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—pancreatic cancer	0.000103	0.000654	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000102	0.00065	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—pancreatic cancer	0.000102	0.000648	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—pancreatic cancer	0.000102	0.000648	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—pancreatic cancer	0.000101	0.000642	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—pancreatic cancer	0.0001	0.000637	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—pancreatic cancer	9.95e-05	0.000632	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—pancreatic cancer	9.93e-05	0.00063	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—pancreatic cancer	9.92e-05	0.000629	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—pancreatic cancer	9.9e-05	0.000628	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—pancreatic cancer	9.88e-05	0.000627	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—pancreatic cancer	9.88e-05	0.000627	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—pancreatic cancer	9.82e-05	0.000623	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—pancreatic cancer	9.75e-05	0.000619	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—pancreatic cancer	9.74e-05	0.000618	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—pancreatic cancer	9.74e-05	0.000618	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—pancreatic cancer	9.7e-05	0.000616	CcSEcCtD
Oxaprozin—Infection—Epirubicin—pancreatic cancer	9.67e-05	0.000614	CcSEcCtD
Oxaprozin—Shock—Epirubicin—pancreatic cancer	9.58e-05	0.000608	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—pancreatic cancer	9.56e-05	0.000607	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—pancreatic cancer	9.54e-05	0.000606	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—pancreatic cancer	9.53e-05	0.000605	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—pancreatic cancer	9.53e-05	0.000605	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—pancreatic cancer	9.5e-05	0.000603	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—pancreatic cancer	9.41e-05	0.000597	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—pancreatic cancer	9.36e-05	0.000594	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—pancreatic cancer	9.28e-05	0.000589	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—pancreatic cancer	9.28e-05	0.000589	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—pancreatic cancer	9.19e-05	0.000583	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—pancreatic cancer	9.18e-05	0.000582	CcSEcCtD
Oxaprozin—Rash—Docetaxel—pancreatic cancer	9.1e-05	0.000578	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—pancreatic cancer	9.1e-05	0.000577	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—pancreatic cancer	9.09e-05	0.000577	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—pancreatic cancer	9.08e-05	0.000577	CcSEcCtD
Oxaprozin—Headache—Docetaxel—pancreatic cancer	9.04e-05	0.000574	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—pancreatic cancer	9.01e-05	0.000572	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—pancreatic cancer	9.01e-05	0.000572	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—pancreatic cancer	8.95e-05	0.000568	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—pancreatic cancer	8.86e-05	0.000563	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—pancreatic cancer	8.82e-05	0.00056	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—pancreatic cancer	8.81e-05	0.000559	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—pancreatic cancer	8.79e-05	0.000558	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—pancreatic cancer	8.74e-05	0.000555	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.71e-05	0.000553	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—pancreatic cancer	8.68e-05	0.000551	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—pancreatic cancer	8.66e-05	0.000549	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—pancreatic cancer	8.59e-05	0.000545	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—pancreatic cancer	8.57e-05	0.000544	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—pancreatic cancer	8.57e-05	0.000544	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—pancreatic cancer	8.46e-05	0.000537	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—pancreatic cancer	8.42e-05	0.000534	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—pancreatic cancer	8.33e-05	0.000528	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—pancreatic cancer	8.15e-05	0.000517	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—pancreatic cancer	8.09e-05	0.000513	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—pancreatic cancer	8.03e-05	0.00051	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—pancreatic cancer	8.02e-05	0.000509	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—pancreatic cancer	8.01e-05	0.000508	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.96e-05	0.000505	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—pancreatic cancer	7.93e-05	0.000503	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—pancreatic cancer	7.83e-05	0.000497	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—pancreatic cancer	7.73e-05	0.000491	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—pancreatic cancer	7.7e-05	0.000489	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—pancreatic cancer	7.7e-05	0.000488	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—pancreatic cancer	7.7e-05	0.000488	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—pancreatic cancer	7.42e-05	0.000471	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	7.37e-05	0.000468	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—pancreatic cancer	7.16e-05	0.000454	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—pancreatic cancer	7.12e-05	0.000452	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—pancreatic cancer	7.12e-05	0.000452	CcSEcCtD
Oxaprozin—Fenbufen—PTGS2—pancreatic cancer	7.06e-05	0.49	CrCbGaD
Oxaprozin—Asthenia—Epirubicin—pancreatic cancer	6.99e-05	0.000443	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—pancreatic cancer	6.89e-05	0.000437	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—pancreatic cancer	6.66e-05	0.000423	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—pancreatic cancer	6.46e-05	0.00041	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—pancreatic cancer	6.44e-05	0.000409	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—pancreatic cancer	6.37e-05	0.000405	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—pancreatic cancer	6.19e-05	0.000393	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—pancreatic cancer	6.16e-05	0.000391	CcSEcCtD
Oxaprozin—Rash—Epirubicin—pancreatic cancer	6.14e-05	0.00039	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—pancreatic cancer	6.13e-05	0.000389	CcSEcCtD
Oxaprozin—Headache—Epirubicin—pancreatic cancer	6.1e-05	0.000387	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—pancreatic cancer	5.96e-05	0.000378	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—pancreatic cancer	5.78e-05	0.000367	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—pancreatic cancer	5.73e-05	0.000364	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—pancreatic cancer	5.68e-05	0.000361	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—pancreatic cancer	5.67e-05	0.00036	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—pancreatic cancer	5.64e-05	0.000358	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—pancreatic cancer	5.35e-05	0.00034	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—pancreatic cancer	4.05e-05	0.281	CrCbGaD
Oxaprozin—Flurbiprofen—PTGS2—pancreatic cancer	3.31e-05	0.229	CrCbGaD
